A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pai
Phase 4
- Conditions
- Diabetic Peripheral Neuropathic Pain
- Registration Number
- JPRN-jRCT1080222824
- Lead Sponsor
- Shionogi & Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
Participants present with pain due to bilateral, peripheral neuropathy.
And et al.
Exclusion Criteria
Participants who have hypersensitivity to multiple medications.
Participants who have undergone renal transplant, or are currently undergoing renal dialysis.
And et al.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change from Baseline in the Weekly Mean of the 24-Hour Average Pain Score
- Secondary Outcome Measures
Name Time Method